Dergiler / Psychiatry and behavioral sciences (Online) / 2020 / Cilt: 10 - Sayı: 1

Anti-Streptolysin O (ASO) Antibodies are Elevated in Patients with First Episode Psychosis and Chronic Schizophrenia Compared to Controls

Sayfa
13–17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Based on these results, streptococcal infections may be related to some central nervous system pathologies such as schizophrenia.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: Increasing evidence demonstrates that infections and activated immune system may play a role in the pathogenesis of schizophrenia.
📊
Temel Bulgular & Veri:Methods: This study included 33 patients with first episode psychosis, 42 patients with chronic schizophrenia, and 41 randomly selected age – and gender-matched healthy volunteers.
💡
Sonuç & Katkı:Based on these results, streptococcal infections may be related to some central nervous system pathologies such as schizophrenia.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: Increasing evidence demonstrates that infections and activated immune system may play a role in the pathogenesis of schizophrenia. In this study, we aimed to investigate the possible relationship between anti-streptolysin O (ASO) antibodies titer and schizophrenia. Methods: This study included 33 patients with first episode psychosis, 42 patients with chronic schizophrenia, and 41 randomly selected age – and gender-matched healthy volunteers. The severity of schizophrenia symptoms in the patients were evaluated using the Positive and Negative Syndrome Scale (PANSS). The enzyme-linked immunosorbent assay (ELISA) method was used to measure ASO titer. Results: Three groups had similar demographic characteristics. The mean ASO titer was 200.23±173.14 IU/ml in patients with first episode psychosis, 151.66±128.74 IU/ml in patients with chronic schizophrenia and 108.56±93.67 IU/ml in healthy controls. According to pairwise comparison; ASO titer of the first episode psychosis and chronic schizophrenia groups were significantly higher than the healthy controls (F=4.367, p=0.015). There was a statistically significant positive correlation between total PANSS score and ASO titer (the total PANSS score increases with ASO titer) (r=0.193, p=0.037). Conclusion: To our knowledge, this study is the first study in the literature investigating ASO titer in patients with first episode psychosis and chronic schizophrenia. The findings of our study suggest that there is a relationship between psychosis severity and ASO titer in both patients with first episode psychosis and chronic schizophrenia. Based on these results, streptococcal infections may be related to some central nervous system pathologies such as schizophrenia.

🔖

Bu Makaleye Atıf Yap

ŞAHPOLAT, M. (2020). Anti-Streptolysin O (ASO) Antibodies are Elevated in Patients with First Episode Psychosis and Chronic Schizophrenia Compared to Controls. Psychiatry and behavioral sciences (Online), Cilt: 10 - Sayı: 1, 13–17. https://ajindex.com/articles/302785

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Venkatasubramanian G, Debnath M. Neuroimmunological aberrations and cerebral asymmetry abnormalities in schizophrenia: select perspectives on pathogenesis. Clin Psychopharmacol Neurosci 2014;12:8-18
  2. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987;44:660-669
  3. Yolken RH, Torrey EF. Are some cases of psychosis caused by microbial agents? A review of the evidence. Molecular Psychiatry 2008;13:470-9
  4. Davis KL, Stewert DG, Friedman JI, et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Archives of General Psychiatry 2003;60:443-56
  5. Sperner-Unterweger B. Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications. Drugs 2005;65:1493-520
  6. Buka SL, Cannon TD, Torrey EF, Yolken RH. Collaborative study group on the perinatal origins of severe psychiatric disorders. Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biological Psychiatry 2008;63:809-15
  7. Bechter K, Bogerts B. Abstracts of the 9th psychoimmunology expert meeting: neuropsychoimmunology of psychoses. Immune and inflammatory aspects of psychoses. In Vivo 2007;21:917-53
  8. Dalman C, Allebeck P, Gunnell D, Harrison G, Kristensson K, Lewis G, et al. Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. The American Journal of Psychiatry 2008;165:59-65
  9. Meyer U, Nyffeler M, Schwendener S, Knuesel I, Yee BK, Feldon J. Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after In Utero immune challenge. Neuropsychopharmacology 2008;33:441-56
  10. Diamond B, Huerta PT, Mina-Osorio P, Kowal C, Volpe BT. Losing your nerves? maybe it’s the antibodies. Nat Rev Immunol 2009;9:449-456
  11. Tanaka S, Matsunaga H, Kimura M, Tatsumi K, et al. Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders. J Neuroimmunol 2003;141:155-164
  12. Irani S, Lang B. Autoantibody-mediated disorders of the central nervous system. Autoimmunity 2008;41:55-65
  13. Margutti P, Delunardo F, Ortona E. Autoantibodies associated with psychiatric disorders. Curr Neurovasc Res 2006;3:149- 157
  14. Graus F, Saiz A, Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 2010;257:509-517
  15. Zandi MS, Irani SR, Lang B, Waters P, Jones PB, McKe